Role of the JAKs/STATs Pathway in the Intracellular Calcium Changes Induced by Interleukin-6 in Hippocampal Neurons

Overview

Journal Neurotox Res

Publisher Springer

Specialty Neurology

Date 2005 Dec 24

PMID 16371324

Citations 32

Authors

D I Orellana

R A Quintanilla

C Gonzalez-Billault

R B Maccioni

Affiliations

Soon will be listed here.

Abstract

Recent studies show that inflammation has an active role in the onset of neurodegenerative diseases. It is known that in response to extracellular insults microglia and/or astrocytes produce inflammatory agents. These contribute to the neuropathological events in the aging process and neuronal degeneration. Interleukin-6 (IL-6) has been involved in the pathogenesis of neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases. Here, we show that IL-6 treatment of rat hippocampal neurons increases the calcium influx via NMDA-receptor, an effect that is prevented by the specific NMDA receptor antagonist MK-801 (dizocilpine). We also show that this calcium influx is mediated by the JAKs/STATs pathway, since the inhibitor of JAKs/STATs pathway, JAK 3 inhibitor, blocks calcium influx even in the presence of IL-6. This increase in calcium signal was dependent on external sources, since this signal was not observed in the presence of EGTA. Additional studies indicate that the increase in cytosolic calcium induces tau protein hyperphosphorylation, as revealed by using specific antibodies against Alzheimer phosphoepitopes. This anomalous tau hyperphosphorylation was dependent on both the JAKs/STATs pathway and NMDA receptor. These results suggest that IL-6 would induce a cascade of molecular events that produce a calcium influx through NMDA receptors, mediated by the JAKs/STATs pathway, which subsequently modifies the tau hyperphosphorylation patterns.

Citing Articles

The Use of Nutraceutical and Pharmacological Strategies in Murine Models of Autism Spectrum Disorder.

Bonetti M, Borsani E, Bonomini F Cells. 2025; 13(24.

PMID: 39768128 PMC: 11675073. DOI: 10.3390/cells13242036.

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions.

Sarapultsev A, Gusev E, Komelkova M, Utepova I, Luo S, Hu D Mol Biomed. 2023; 4(1):40.

PMID: 37938494 PMC: 10632324. DOI: 10.1186/s43556-023-00151-1.

Janus kinase inhibitors are potential therapeutics for amyotrophic lateral sclerosis.

Richardson P, Smith D, de Giorgio A, Snetkov X, Almond-Thynne J, Cronin S Transl Neurodegener. 2023; 12(1):47.

PMID: 37828541 PMC: 10568794. DOI: 10.1186/s40035-023-00380-y.

Prolonged STAT1 activation in neurons drives a pathological transcriptional response.

Clark D, ONeil S, Xu L, Steppe J, Savage J, Raghunathan K J Neuroimmunol. 2023; 382:578168.

PMID: 37556887 PMC: 10527980. DOI: 10.1016/j.jneuroim.2023.578168.

Extracellular CIRP Induces Calpain Activation in Neurons via PLC-IP-Dependent Calcium Pathway.

Sharma A, Sari E, Lee Y, Patel S, Brenner M, Marambaud P Mol Neurobiol. 2023; 60(6):3311-3328.

PMID: 36853429 PMC: 10506840. DOI: 10.1007/s12035-023-03273-3.

References

Frei K, Fredrikson S, Fontana A, Link H . Interleukin-6 is elevated in plasma in multiple sclerosis. J Neuroimmunol. 1991; 31(2):147-53. DOI: 10.1016/0165-5728(91)90020-8. View

Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P . Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett. 1995; 202(1-2):17-20. DOI: 10.1016/0304-3940(95)12192-7. View

Ershler W, Keller E . Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med. 2000; 51:245-70. DOI: 10.1146/annurev.med.51.1.245. View

LaFerla F . Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci. 2002; 3(11):862-72. DOI: 10.1038/nrn960. View

Mehlhorn G, Hollborn M, Schliebs R . Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci. 2000; 18(4-5):423-31. DOI: 10.1016/s0736-5748(00)00012-5. View

Grau G, Frei K, Piguet P, Fontana A, Heremans H, Billiau A . Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med. 1990; 172(5):1505-8. PMC: 2188677. DOI: 10.1084/jem.172.5.1505. View

Sriram K, Benkovic S, Hebert M, Miller D, OCallaghan J . Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway.... J Biol Chem. 2004; 279(19):19936-47. DOI: 10.1074/jbc.M309304200. View

Qiu Z, Sweeney D, Netzeband J, Gruol D . Chronic interleukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci. 1998; 18(24):10445-56. PMC: 6793367. View

Toro V, Tehranian R, ZETTERSTROM M, Eriksson G, Langel U, Bartfai T . Increased gene expression of interleukin-1alpha and interleukin-6 in rat primary glial cells induced by beta-amyloid fragment. J Mol Neurosci. 2002; 17(3):341-50. DOI: 10.1385/jmn:17:3:341. View

10.

Minami M, Kuraishi Y, Satoh M . Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun. 1991; 176(2):593-8. DOI: 10.1016/s0006-291x(05)80225-6. View

11.

Campbell I, Abraham C, Masliah E, Kemper P, Inglis J, Oldstone M . Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A. 1993; 90(21):10061-5. PMC: 47713. DOI: 10.1073/pnas.90.21.10061. View

12.

Alvarez A, Toro R, Caceres A, Maccioni R . Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death. FEBS Lett. 1999; 459(3):421-6. DOI: 10.1016/s0014-5793(99)01279-x. View

13.

Del Bo R, Angeretti N, Lucca E, De Simoni M, Forloni G . Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci Lett. 1995; 188(1):70-4. DOI: 10.1016/0304-3940(95)11384-9. View

14.

Gadient R, Lachmund A, Unsicker K, Otten U . Expression of interleukin-6 (IL-6) and IL-6 receptor mRNAs in rat adrenal medulla. Neurosci Lett. 1995; 194(1-2):17-20. DOI: 10.1016/0304-3940(95)11708-5. View

15.

Apelt J, Schliebs R . Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology. Brain Res. 2001; 894(1):21-30. DOI: 10.1016/s0006-8993(00)03176-0. View

16.

Patrick G, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai L . Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature. 1999; 402(6762):615-22. DOI: 10.1038/45159. View

17.

Gadient R, Otten U . Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials. Prog Neurobiol. 1997; 52(5):379-90. DOI: 10.1016/s0301-0082(97)00021-x. View

18.

Sengupta T, Schmitt E, Ivashkiv L . Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc Natl Acad Sci U S A. 1996; 93(18):9499-504. PMC: 38457. DOI: 10.1073/pnas.93.18.9499. View

19.

Jee S, Chu C, Chiu H, Huang Y, Tsai W, Liao Y . Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways. J Invest Dermatol. 2004; 123(6):1169-75. DOI: 10.1111/j.0022-202X.2004.23497.x. View

20.

Holliday J, Parsons K, Curry J, Lee S, Gruol D . Cerebellar granule neurons develop elevated calcium responses when treated with interleukin-6 in culture. Brain Res. 1995; 673(1):141-8. DOI: 10.1016/0006-8993(94)01417-g. View